Make Informed Investment Decisions with Affordable Access to Experts
Checking in on the Voxelator Launch With A Sickle Cell Expert (2 week delayed release to library)Ticker(s): GBT
Name: Dr Richard Drachtman - MD
Institution: Rutgers Medical School
- Interim Chief, Pediatric Hematology/Oncology and Director, Comprehensive Sickle Cell Center at Rutgers Cancer Institute of New Jersey; Vice Chair, IRB at Rutgers Biomedical and Health Sciences; and Vice Chair, NCI Pediatric Central IRB.
- Currently manages 400 patients with sickle cell disease.
- Research focuses on Hodgkin Disease, Pediatric oncology/ hematology, and Sickle cell disease.
Please describe your clinical practice; roughly how many patients with sickle cell disease do you currently manageAdded By: c_admin
What you thought of the phase III results for voxelator?Added By: c_admin
Has payor approval been a concern for your patients?Added By: c_admin
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.